Dechra Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
12.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
11.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
10.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
09.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
08.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
05.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
04.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
03.01.24	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
29.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
28.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
26.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
22.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
21.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
20.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
19.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
18.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
15.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
14.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
12.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
11.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
08.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
07.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
05.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
04.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
01.12.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
30.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
29.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
28.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
27.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
24.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
23.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
21.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
17.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
16.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
15.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
14.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
13.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
10.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
08.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
07.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
06.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
02.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
01.11.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
31.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
27.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
26.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC (EQS Group)
25.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
24.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)
20.10.23	Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

20.12.23		Aufschläge in London: FTSE 100 liegt schlussendlich im Plus
20.12.23		LSE-Handel: FTSE 100 beginnt Handel im Plus
13.12.23		Gewinne in London: Börsianer lassen FTSE 100 zum Start des Mittwochshandels steigen
12.12.23		Anleger in London halten sich zurück: FTSE 100 legt letztendlich den Rückwärtsgang ein
12.12.23		Gute Stimmung in London: Am Dienstagnachmittag Gewinne im FTSE 100
12.12.23		LSE-Handel: So entwickelt sich der FTSE 100 mittags
12.12.23		Gute Stimmung in London: FTSE 100 zum Start freundlich
11.12.23		Schwache Performance in London: FTSE 100 zum Ende des Montagshandels mit Abgaben

20.12.23

Aufschläge in London: FTSE 100 liegt schlussendlich im Plus

20.12.23

LSE-Handel: FTSE 100 beginnt Handel im Plus

13.12.23

Gewinne in London: Börsianer lassen FTSE 100 zum Start des Mittwochshandels steigen

12.12.23

Anleger in London halten sich zurück: FTSE 100 legt letztendlich den Rückwärtsgang ein

12.12.23

Gute Stimmung in London: Am Dienstagnachmittag Gewinne im FTSE 100

12.12.23

LSE-Handel: So entwickelt sich der FTSE 100 mittags

12.12.23

Gute Stimmung in London: FTSE 100 zum Start freundlich

11.12.23

Schwache Performance in London: FTSE 100 zum Ende des Montagshandels mit Abgaben

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	147.80	2.67 %	K V
Givaudan	3’529.00	0.92 %	K V
Swisscom	588.50	0.77 %	K V
Zurich Insur Gr	576.00	0.49 %	K V
Swiss Life Hldg	834.00	0.31 %	K V
Holcim	67.08	-0.77 %	K V
Sika	185.65	-0.83 %	K V
UBS Group	31.95	-0.96 %	K V
Kuehne+Nagel Int	164.85	-1.20 %	K V
Nestle	73.54	-1.58 %	K V

Dechra Pharmaceuticals Aktie VALOR 1132777 / ISIN GB0009633180

Nachrichten zu Dechra Pharmaceuticals PLC

Aktien Top/Flop

Dechra Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten